Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001079973-20-000628
Filing Date
2020-07-28
Accepted
2020-07-28 15:22:31
Documents
1
Group Members
IBEX GP LLCIBEX INVESTMENT HOLDINGS II LLCIBEX INVESTMENT HOLDINGS LLCIBEX ISRAEL FUND LLLPJUSTIN B. BORUS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ibex_galmed-13g.htm SC 13G 150370
  Complete submission text file 0001079973-20-000628.txt   152158
Mailing Address 260 N. JOSEPHINE STREET SUITE 300 DENVER CO 80206
Business Address 260 N. JOSEPHINE STREET SUITE 300 DENVER CO 80206 303-500-8821
Ibex Investors LLC (Filed by) CIK: 0001531964 (see all company filings)

EIN.: 331042318 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Subject) CIK: 0001595353 (see all company filings)

EIN.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88495 | Film No.: 201053674
SIC: 2834 Pharmaceutical Preparations